Interlochen Center for the Arts Announces Challenge for Student Scholarship Support
Apr 17, 2018 17:29 pm UTC| Business
Interlochen, Mich., April 17, 2018 -- Dr. Mohamed A. El-Erian, internationally respected economist and devoted Interlochen supporter, is championing scholarship opportunities for young artists and encouraging others to...
Apr 17, 2018 17:25 pm UTC| Business
First Approved Therapy for XLH in the U.S.; Only Treatment that Targets the Underlying Cause of this Rare, Hereditary, Lifelong Disease Ultragenyx to Host Conference Call Today at 4:30 pm Eastern Time NOVATO, Calif....
Army Chaplain Asks to be Spared from Career-Ending Punishment for Religious Beliefs
Apr 17, 2018 17:20 pm UTC| Business
FT. BRAGG, N.C., April 17, 2018 -- First Liberty Institute today sent a letter to the U.S. Army urging it to reverse an investigator’s decision and recommendation that First Liberty client, Army Chaplain Scott Squires,...
Apr 17, 2018 17:13 pm UTC| Business
HOUSTON, April 17, 2018 -- McDermott International, Inc. (“McDermott”) (NYSE:MDR) today announced that Institutional Shareholder Services Inc. (“ISS”), a leading independent proxy advisory firm, has recommended that...
CV Holdings, Inc. Update and Financial Statements for Year Ended December 31, 2017
Apr 17, 2018 17:13 pm UTC| Business
NEWPORT BEACH, Calif., April 17, 2018 -- CV Holdings, Inc. (Other OTC:CVHL) (the “Company”) today reported a net loss for the year ended December 31, 2017 of $(8,658,577) or $(0.16) per common share with weighted...
PRINCE NEO, Part Three of Chronicles of Ethereum, Published by Strategic Coin
Apr 17, 2018 17:06 pm UTC| Business
NEW YORK, NY, April 17, 2018 -- Strategic Coin, a leading crypto-research and advisory company, today published Part Three: “PRINCE NEO” of the company’s five-part, in-depth research series entitled: Chronicles of...
Apr 17, 2018 17:01 pm UTC| Business
Detailed Characterization of Unique DolaLock Technology Enhancements to Drug Efficacy and Tolerability XMT-1522 Demonstrates Synergy in Combination with a Checkpoint Inhibitor CAMBRIDGE, Mass., April 17, 2018 --...